Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets

Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets Homegrown Covaxin was to play a major role in vaccination against Covid-19. But eight months after the vaccination drive began, only one in 11 Indians has managed to get the first indigenous vaccine. Bharat Biotech, which manufactures it, has failed to ramp up production at the pace it had envisaged. https://ift.tt/eA8V8J